Cetrelimab Clinical Trials
6 recruitingDrug
Phase 15Phase 21
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Study of JNJ-1761981 in Participants With Solid Tumors
Neoplasms
Johnson & Johnson Enterprise Innovation Inc.66 enrolled2 locationsNCT07525141
Recruiting
Phase 1
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Carcinoma, Non-Small Cell Lung
Johnson & Johnson Enterprise Innovation Inc.126 enrolled15 locationsNCT06116786
Recruiting
Phase 1
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Metastatic Hormone Sensitive Prostate CancerMetastatic Castration-resistant Prostate Neoplasms
Janssen Research & Development, LLC300 enrolled15 locationsNCT05818683
Recruiting
Phase 1
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Neoplasms
Johnson & Johnson Enterprise Innovation Inc.126 enrolled10 locationsNCT06311578
Recruiting
Phase 2
CD8 PET Imaging in Metastatic Solid Tumours
Locally Advanced Solid Tumor
University Medical Center Groningen30 enrolled4 locationsNCT06534190
Recruiting
Phase 1
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Ankyra Therapeutics, Inc60 enrolled5 locationsNCT07027514